Skip to main content
. 2020 Jun 12;12(6):1551. doi: 10.3390/cancers12061551

Table 3.

Comparing mortality rates between aspirin users (≥ 180 days) and non-users in patients (n = 565) with Stages I and II and III and IV NPC.

AJCC
n = 565
Low-Dose Aspirin X2 Aspirin Non-Users vs. Users p-Value
Non-Users n = 452 Users ≥ 180 Days n = 113 Aspirin Non-Users vs. Users Stages I and II vs. III and IV a
Stages I and II <0.001 ***
Alive 146 (79.8%) 41 (85.4%) 2.395 0.302
Dead due to NPC 20 (10.9%) 2 (4.2%)
Other Causes of Dead 17 (9.3%) 5 (10.4%)
Stages III and IVa
Alive 139 (51.7%) 55 (84.6%) 23.364 <0.001 ***
Dead due to NPC 96 (35.7%) 7 (10.8%)
Other Causes of Dead 34 (12.6%) 3 (4.6%)

Abbreviation: vs. versus. a Stages IVa and IVb only; **** p ≤ 0.001.